Showing results (1431-1440 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 4, 2025
Gene Therapy for the Treatment of Osteoarthritis: Advances and ProspectiveAnjali Rana, Rishabha Malviya, Shivam Rajput, et al.Current Pharmaceutical Design|July 31, 2025
Quercetin and Citreorosein from Halodule uninervis Leaf Show the Best Binding Against Breast Cancer Targets AKT1, EGFR, and ESR1Tapas Ranjan Samala, Priyankar SenCurrent Pharmaceutical Design|March 28, 2025
CRNDE, a Potential Therapeutic Target in Human DiseasesShiyun Zeng, Yao Xie, Yulan Shi, et al.Current Pharmaceutical Design|September 13, 2013
Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousnessOlivia Gosseries, Vanessa Charland-Verville, Marie Thonnard, et al.Current Pharmaceutical Design|September 13, 2013
General anesthetics in brain injury: friends or foes?Laszlo VutskitsCurrent Pharmaceutical Design|September 13, 2013
Restoring cortical connectivity directionality and synchronization is essential to treating disorder of consciousnessJose León-Carrión, Umberto León-Dominguez, James Halper, et al.Current Pharmaceutical Design|September 13, 2013
Imaging requirements for personalized medicine: the oncologists point of viewV Kruse, S Van Belle, V CocquytCurrent Pharmaceutical Design|September 13, 2013
Radiolabelled probes targeting infection and inflammation for personalized medicineAlberto Signore, Chiara Lauri, Filippo GalliCurrent Pharmaceutical Design|September 5, 2013
In silico screening for potent inhibitors against the NS3/4A protease of hepatitis C virusArthitaya Meeprasert, Thanyada Rungrotmongkol, Mai Suan Li, et al.Current Pharmaceutical Design|September 5, 2013
Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1Thanyarat Udommaneethanakit, Thanyada Rungrotmongkol, Vladimir Frecer, et al.Pageof 1,008